Literature DB >> 28089882

A highly efficient modified human serum albumin signal peptide to secrete proteins in cells derived from different mammalian species.

Carolina Attallah1, Marina Etcheverrigaray2, Ricardo Kratje2, Marcos Oggero2.   

Abstract

Signal peptides (SPs) are key elements in the production of recombinant proteins; however, little information is available concerning different SP in mammalian cells other than CHO. In order to study the efficiency of different SPs to direct the traffic along the secretory pathway of the green fluorescence protein (GFP) and a scFv-Fc fusion protein; CHO-K1, HEK293 and NS0 cell lines were transfected in a transient and stable way. SP of human azurocidin (AZ), modified human albumin (mSA), modified Cricetulus griseus Ig kappa chain V III region MOPC 63 like (mIgκ C) and modified human Ig kappa chain V III region VG (mIgκ H) were evaluated. The efficiency of SPs to translocate a propeptide across the ER membrane was evaluated by fluorescence microscopy and flow cytometry for the GFP inside the secretory pathway, and by antigen-specific indirect ELISA for the scFv-Fc outside the cell. The mSA SP was successful in directing the secretion of the active proteins in these different types of mammalian cells, regardless of the transgene copy number. The goal of this work was to demonstrate that a modified version of SA SP might be used in different mammalian cells employing the same expression vector.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mammalian cells; Protein secretory pathway; Serum albumin signal peptide; Signal peptide

Mesh:

Substances:

Year:  2017        PMID: 28089882     DOI: 10.1016/j.pep.2017.01.003

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  5 in total

1.  Development of an in vitro screening system for synthetic signal peptide in mammalian cell-based protein production.

Authors:  Jong-Ho Park; Hoon-Min Lee; Eun-Ju Jin; Eun-Ji Lee; Yeon-Ju Kang; Sungkyun Kim; Sung-Sick Yoo; Gyun Min Lee; Yeon-Gu Kim
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-18       Impact factor: 4.813

2.  Essentially Leading Antibody Production: An Investigation of Amino Acids, Myeloma, and Natural V-Region Signal Peptides in Producing Pertuzumab and Trastuzumab Variants.

Authors:  Wei-Li Ling; Chinh Tran-To Su; Wai-Heng Lua; Jun-Jie Poh; Yuen-Ling Ng; Anil Wipat; Samuel Ken-En Gan
Journal:  Front Immunol       Date:  2020-12-07       Impact factor: 7.561

Review 3.  Strategies and Considerations for Improving Recombinant Antibody Production and Quality in Chinese Hamster Ovary Cells.

Authors:  Jun-He Zhang; Lin-Lin Shan; Fan Liang; Chen-Yang Du; Jing-Jing Li
Journal:  Front Bioeng Biotechnol       Date:  2022-03-04

4.  Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistance.

Authors:  Justin D Walter; Melanie Scherer; Cedric A J Hutter; Alisa A Garaeva; Iwan Zimmermann; Marianne Wyss; Jan Rheinberger; Yelena Ruedin; Jennifer C Earp; Pascal Egloff; Michèle Sorgenfrei; Lea M Hürlimann; Imre Gonda; Gianmarco Meier; Sille Remm; Sujani Thavarasah; Geert van Geest; Rémy Bruggmann; Gert Zimmer; Dirk J Slotboom; Cristina Paulino; Philippe Plattet; Markus A Seeger
Journal:  EMBO Rep       Date:  2022-03-07       Impact factor: 8.807

5.  Large Area Microfluidic Bioreactor for Production of Recombinant Protein.

Authors:  Natalia Bourguignon; Paola Karp; Carolina Attallah; Daniel A Chamorro; Marcos Oggero; Ross Booth; Sol Ferrero; Shekhar Bhansali; Maximiliano S Pérez; Betiana Lerner; Gustavo Helguera
Journal:  Biosensors (Basel)       Date:  2022-07-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.